DexCom Inc logo

DexCom Inc

DXCM · NASDAQ · Medical devices, Biotech · Founded 1999

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Current Price
$79.93
Market Cap
$30.2B
Return Since Last Split
+20%
Last Split
Jun 13, 2022
Total Splits
1
Cumulative Multiple
4×

What If You Bought DXCM Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$31,972
400 shares · 4×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth from that date to today.

Split DatePrice BeforeRatioSplit MultipleCumulative
Jun 13, 2022$73.464-for-14×4×

DexCom Inc Market Cap Timeline

Validated annual market-cap history is available from 2005. Split markers cover all 1 recorded split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Frequently Asked Questions

DexCom Inc's latest record in the split calendar is a 4-for-1 forward split effective 2022-06-13.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.